Igor Lisukov

1.3k total citations
20 papers, 438 citations indexed

About

Igor Lisukov is a scholar working on Immunology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Igor Lisukov has authored 20 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Hematology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Igor Lisukov's work include Complement system in diseases (5 papers), Mesenchymal stem cell research (4 papers) and Multiple Sclerosis Research Studies (4 papers). Igor Lisukov is often cited by papers focused on Complement system in diseases (5 papers), Mesenchymal stem cell research (4 papers) and Multiple Sclerosis Research Studies (4 papers). Igor Lisukov collaborates with scholars based in Russia, United States and United Kingdom. Igor Lisukov's co-authors include Alexander Kulagin, Kozlov Va, Takako Tsujimoto, Atsushi Kuramoto, N Huang, Maged S. Mahmoud, Michio Kawano, Yuka Harada, Е. Р. Черных and O. Yu. Leplina and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Igor Lisukov

19 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Lisukov Russia 9 205 165 130 95 71 20 438
Dale Frank United States 13 186 0.9× 213 1.3× 75 0.6× 118 1.2× 11 0.2× 30 520
Norbert-Claude Gorin France 8 159 0.8× 145 0.9× 150 1.2× 80 0.8× 37 0.5× 13 439
Rongfeng Fu China 13 66 0.3× 258 1.6× 134 1.0× 52 0.5× 18 0.3× 71 468
T Olee United States 10 261 1.3× 127 0.8× 51 0.4× 35 0.4× 18 0.3× 13 525
Ayumi Okuyama Japan 11 91 0.4× 47 0.3× 100 0.8× 95 1.0× 45 0.6× 23 445
Marie‐Laure Bonnet France 11 73 0.4× 373 2.3× 266 2.0× 34 0.4× 18 0.3× 20 565
Laetitia Languille France 10 46 0.2× 363 2.2× 157 1.2× 65 0.7× 55 0.8× 25 521
Shokichi Tsukamoto Japan 13 90 0.4× 198 1.2× 63 0.5× 44 0.5× 8 0.1× 39 382
April Chang‐Miller United States 7 74 0.4× 41 0.2× 76 0.6× 32 0.3× 21 0.3× 11 364
Bernadette Guerton France 8 83 0.4× 187 1.1× 165 1.3× 16 0.2× 19 0.3× 13 424

Countries citing papers authored by Igor Lisukov

Since Specialization
Citations

This map shows the geographic impact of Igor Lisukov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Lisukov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Lisukov more than expected).

Fields of papers citing papers by Igor Lisukov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Lisukov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Lisukov. The network helps show where Igor Lisukov may publish in the future.

Co-authorship network of co-authors of Igor Lisukov

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Lisukov. A scholar is included among the top collaborators of Igor Lisukov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Lisukov. Igor Lisukov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Socié, Gèrard, Hubert Schrezenmeier, Petra Muus, et al.. (2016). Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry. Internal Medicine Journal. 46(9). 1044–1053. 58 indexed citations
2.
Lisukov, Igor, Alexander Kulagin, & Boris V. Afanasyev. (2014). Treatment of paroxysmal nocturnal hemoglobinuria. SHILAP Revista de lepidopterología. 1 indexed citations
4.
Babenko, Elena V., Elena Boyakova, А. М. Попов, et al.. (2014). An inter-laboratory comparison of PNH clone detection by high-sensitivity flow cytometry in a Russian cohort. Hematology. 20(1). 31–38. 14 indexed citations
5.
Kulagin, Alexander, et al.. (2014). Long-Term Outcomes of Accelerated Telomere Shortening in Acquired Aplastic Anemia. Blood. 124(21). 4396–4396. 2 indexed citations
6.
Дедов, И. И., Igor Lisukov, & Д. Н. Лаптев. (2014). Modern possibilities for using stem cells in diabetes mellitus. Diabetes Mellitus. 17(2). 20–28. 1 indexed citations
8.
Kulagin, Alexander, Igor Lisukov, Sergey N. Bondarenko, et al.. (2013). Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two‐centre prospective study. British Journal of Haematology. 164(4). 546–554. 78 indexed citations
9.
Черных, Е. Р., Е. Ya. Shevela, Alexander Kulagin, et al.. (2012). Rapid Recovery from Chronic PRCA by MSC Infusion in Patient after Major ABO-Mismatched alloSCT. Case Reports in Medicine. 2012. 1–4. 5 indexed citations
10.
Novik, Andrei A., B. V. Аfanasiev, Igor Lisukov, et al.. (2008). High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis. Experimental Hematology. 36(8). 922–928. 39 indexed citations
11.
Черных, Е. Р., Е. Ya. Shevela, O. Yu. Leplina, et al.. (2007). Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bulletin of Experimental Biology and Medicine. 143(4). 543–547. 69 indexed citations
12.
Черных, Е. Р., O. Yu. Leplina, Е. Ya. Shevela, et al.. (2007). Autologous bone marrow cells in the treatment of cirrhosis of the liver. Bulletin of Experimental Biology and Medicine. 144(4). 640–645. 13 indexed citations
13.
Kulagin, Alexander, et al.. (2007). Cytokine-producing activity of bone marrow erythrokaryocytes and its regulation under normal conditions. Bulletin of Experimental Biology and Medicine. 143(2). 218–221. 6 indexed citations
14.
Novik, Andrei A., B. V. Аfanasiev, Igor Lisukov, et al.. (2005). Treatment Outcomes in Multiple Sclerosis (MS) Patients after Early, Conventional and Salvage High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT).. Blood. 106(11). 5467–5467. 1 indexed citations
15.
Lisukov, Igor, Alexander Kulagin, Е. В. Зонова, et al.. (2004). High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus. Lupus. 13(2). 89–94. 29 indexed citations
16.
Аfanasiev, B. V., Igor Lisukov, Tatyana Ionova, et al.. (2004). Clinical and Quality of Life Outcomes in Patients with Multiple Sclerosis (MS) after High Dose Chemotherapy(HDCT)+Autologous Stem Cell Transplantation (ASCT).. Blood. 104(11). 1875–1875. 1 indexed citations
17.
Novik, Andrei A., et al.. (2003). 183Clinical and quality of life monitoring in multiple sclerosis patients undergoing high dose chemotherapy and autologous stem cell transplantation. Biology of Blood and Marrow Transplantation. 9(2). 119–119. 2 indexed citations
18.
Harada, Yuka, Michio Kawano, N Huang, et al.. (1996). Identification of early plasma cells in peripheral blood and their clinical significance. British Journal of Haematology. 92(1). 184–191. 93 indexed citations
19.
Kawano, Michio, Maged S. Mahmoud, N Huang, et al.. (1995). High proportions of VLA‐5 immature myeloma cells correlated well with poor response to treatment in multiple myeloma. British Journal of Haematology. 91(4). 860–864. 17 indexed citations
20.
Lisukov, Igor, et al.. (1988). Suppressive effect of AKR mouse blast cells on antibody formation in vivo and lymphocyte proliferation in vitro. Bulletin of Experimental Biology and Medicine. 105(2). 212–215. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026